$100.4M in CY2024 Part D spend1.2M claims · 387K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Tolterodine used for?
Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see Clinical Studies (14) ] .
Is there a generic for Tolterodine?
Yes. 26 ANDAs filed at FDA, 12 generic manufacturers currently shipping.
How much does my plan pay for Tolterodine?
Across 329 Part D plans, Tolterodine averages $0.212/unit (NADAC). Lowest available: $0.206/unit. Highest in distribution: $0.237/unit.
Is Tolterodine on the FDA shortage list?
No. Tolterodine is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.